Dysregulated expression of monoacylglycerol lipase is a marker for anti-diabetic drug metformin-targeted therapy to correct impaired neurogenesis and spatial memory in Alzheimer's disease
Keyword(s):
Keyword(s):
2011 ◽
Vol 32
(3)
◽
pp. 407-418
◽
2010 ◽
Vol 88
(10)
◽
pp. 2103-2117
◽
Keyword(s):
2013 ◽
Vol 38
(3)
◽
pp. 633-646
◽
2019 ◽
Vol 25
(2)
◽
pp. 152-156
Keyword(s):